Fox Chase Cancer Center Welcomes Dr. Joyce G. Habib

Dr. Habib
Fox Chase Cancer Center is pleased to announce the hiring of Joyce G. Habib, MD, as an Assistant Professor in the breast medical oncology program in the Department of Hematology/Oncology.

PHILADELPHIA (February 22, 2024) — Fox Chase Cancer Center is pleased to announce the hiring of Joyce G. Habib, MD, as an Assistant Professor in the breast medical oncology program in the Department of Hematology/Oncology.

Habib attended the American University of Beirut in Lebanon, where she obtained her medical doctorate degree followed by her first year of residency in internal medicine. She completed her internal medicine training and then her fellowship in medical oncology at Baylor University Medical Center. She did postfellowship training in clinical research at the Jules Bordet Institute in Brussels.

Her first academic appointment was as assistant professor in the division of hematology/oncology from July 2020 to July 2021 at the University of Arkansas, where she focused on breast cancer. She has worked as a consulting oncologist at the Fouad Khoury Hospital and Sacre Coeur Hospital in Beirut and as a consulting oncologist in breast and gynecological cancers at Healthbay Polyclinic in Dubai.

More recently, she worked as a medical oncology consultant at Al Zahra University Hospital in Beirut, where she focused on solid tumors and benign and malignant hematology.

Habib is the founder of, a nongovernmental organization that aims to improve cancer literacy and provide access to oncology and supportive care in the Middle East. She is also currently an expert consultant for the World Health Organization in Geneva, where she provides technical inputs and edits to WHO tools related to global and/or national investment cases and forecasting access to cancer medicines and the implementation of the global platform for access to childhood cancer medicines.

She has played a leading role in the development and implementation of effective strategies to reduce the economic burden of cancer care in Lebanon and contributed to the country’s first national cancer control plan.

Habib is board certified in internal medicine and medical oncology. She is a member of the American Society of Clinical Oncology, the European Society for Medical Oncology, and the Lebanese Society of Medical Oncology. She speaks English, French, and Arabic.

Fox Chase Cancer Center (Fox Chase), which includes the Institute for Cancer Research and the American Oncologic Hospital and is a part of Temple Health, is one of the leading comprehensive cancer centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase is also one of just 10 members of the Alliance of Dedicated Cancer Centers. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence six consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. It is the policy of Fox Chase Cancer Center that there shall be no exclusion from, or participation in, and no one denied the benefits of, the delivery of quality medical care on the basis of race, ethnicity, religion, sexual orientation, gender, gender identity/expression, disability, age, ancestry, color, national origin, physical ability, level of education, or source of payment.

For more information, call 888-369-2427